Results 211 to 220 of about 14,183,882 (362)
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy+12 more
wiley +1 more source
Reducing PKCδ inhibits tumor growth through growth hormone by inhibiting PKA/CREB/ERK signaling pathway in pituitary adenoma. [PDF]
Chen X+10 more
europepmc +1 more source
CONCERNING THE INFLUENCE OF POLARIZED LIGHT ON THE GROWTH OF SEEDLINGS [PDF]
David I. Macht
openalex +1 more source
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen+6 more
wiley +1 more source
Height Growth Modeling in Ethiopian Children and Adolescents Aged 7-20 Years: A Prospective Cohort Study. [PDF]
Debeko DD, Goshu AT.
europepmc +1 more source
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
Effect of daily thinning on biweekly increment of growth and yield of maize (Zea mays L.) in mountainous agroecosystem. [PDF]
Arshad M+9 more
europepmc +1 more source
Population Growth and Control in Relation to World Peace [PDF]
Warren S. Thompson
openalex +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source